New leadership will drive expansion and innovation to improve access to chemical compounds and accelerate global drug discovery and development. RIGA, LATVIA (3 SEPTEMBER, 2024) – Molport, the compound sourcing specialist, announces the appointment of Diana Zelencova-Gopejenko, Ph.D. as CEO, from 2nd September 2024. The appointment replaces co-founder and CEO Imants Zudans, Ph.D. after a 17-year tenure. Under new leadership, Molport plans to both expand its current offering and introduce new, tailored MedChem tools…